NYSE · HCA
HCA Healthcare, Inc.
$478.08+$14.86 (+3.21%)
HCA Healthcare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.09% below the high.
Loading market information…
NYSE · PACS · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
PACS Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.39% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
PACS Group, Inc.’s next earnings report is currently expected on Nov 3, 2026, with estimated earnings per share of $0.58. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow PACS Group, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
PACS Group, Inc. operates as a holding company, primarily focused on delivering post-acute healthcare services. This encompasses operating various facilities, providing skilled professionals, and offering essential ancillary support. The company further specializes in providing a spectrum of senior living options, encompassing dedicated senior care, assisted living, and independent living residences in select communities. Founded in 2013 by Jason Murray and Mark Hancock, its corporate headquarters are located in Farmington, Utah.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 |
|---|
| May 19, 2025 |
| $0.42-0.92% vs estimate |
| $1.10B+0.94% vs estimate |
| Q4 2024 | Feb 26, 2025 | $0.39-1.19% vs estimate | $1.04B-1.07% vs estimate |
|---|
| Q3 2024 | Nov 8, 2024 | $0.35+2.94% vs estimate | $995.20M+0.35% vs estimate |
|---|
THE ANALYST VIEW
8 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 3 contributors · Median target $60.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$478.08+$14.86 (+3.21%)
HCA Healthcare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.09% below the high.
$131.49+$9.41 (+7.7%)
Encompass Health Corporation’s quoted price sits in the upper half of its reported 52-week range, 1.69% below the high.
$186.32+$2.21 (+1.2%)
The Ensign Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.53% below the high.
$13.64+$0.25 (+1.83%)
LifeStance Health Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.11% below the high.
$212.16+$0.37 (+0.17%)
National HealthCare Corporation’s quoted price sits in the upper half of its reported 52-week range, 14.52% below the high.
$10.27+$0.29 (+2.91%)
Brookdale Senior Living Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.91% below the high.
$42.48+$0.32 (+0.76%)
The Pennant Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.14% below the high.
$210.10-$2.53 (-1.19%)
Nutex Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 7.1% below the high.
